Results 261 to 270 of about 5,702,046 (400)
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
Molecular Oncology, EarlyView.The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source
Molecular Oncology, EarlyView.This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo +6 more
wiley +1 more source
Indirect Horizontal Application of the Right to Have Access to Health Care Services
, 2007 Marius Pieterse
openalex +2 more sources
Reclaiming Sexual and Reproductive Rights Through a Decolonial Lens [PDF]
Health and Human RightsTlaleng Mofokeng
doaj
Structural factors shaping health-seeking behaviour among breast cancer survivors in the Gaza Strip: A qualitative study utilising the right to health framework. [PDF]
PLOS Glob Public HealthAmmar-Shehada W +3 more
europepmc +1 more source
The Right to Health of Older People.
The gerontologist, 2016 B. Baer +4 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
Freedom Dreaming: On “Emerging Frameworks of Health and Human Rights” [PDF]
Health and Human RightsTlaleng Mofokeng
doaj